无监督机器学习放射组学特征预测早期非小细胞肺癌立体定向放疗患者的治疗反应和总生存
本研究基于100例连续接受立体定向体部放疗的早期非小细胞肺癌患者的18F-FDG-PET数据集,提取722个放射组学特征,采用无监督双向聚类方法同时识别患者分组与放射组学特征。将患者聚为3组时,2组间在生存(p=0.003)和无淋巴结失败(p=0.038)方面存在差异,预测生存和淋巴结失败的平均一致性度量分别为0.640±0.029和0.664±0.063,优于基于临床变量构建的预测模型(p<0.04)。
要点
- 无监督双向聚类可同时分层患者并提取放射组学元特征。
- 聚为3组时2组间生存(p=0.003)和无淋巴结失败(p=0.038)存在差异。
- 放射组学模型预测生存和淋巴结失败的一致性优于临床变量模型(p<0.04)。
核心结论
- 该方法可对患者进行分层,并以优于现有替代方法的性能预测生存和无淋巴结失败。
研究设计与样本
- 基于100例连续接受立体定向体部放疗的早期非小细胞肺癌患者的18F-FDG-PET数据集。
- 每位患者肿瘤提取722个放射组学特征,采用无监督双向聚类方法同时识别患者分组和放射组学特征。
- 比较患者分组间的生存和无淋巴结失败,并计算元特征构建生存模型以预测生存和无淋巴结失败。
主要发现
- 将患者聚为3组时,2组间在生存(p=0.003)和无淋巴结失败(p=0.038)方面存在差异。
- 预测生存和淋巴结失败的平均一致性度量分别为0.640±0.029和0.664±0.063,优于基于临床变量构建的预测模型(p<0.04)。
关键数值与推荐
- 预测生存的平均一致性度量为0.640±0.029,优于临床变量模型(p<0.04)。
- 预测淋巴结失败的平均一致性度量为0.664±0.063,优于临床变量模型(p<0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To predict treatment response and survival of NSCLC patients receiving stereotactic body radiation therapy (SBRT), we develop an unsupervised machine learning method for stratifying patients and extracting meta-features simultaneously based on imaging data. MATERIAL AND METHODS: This study was performed based on an 18F-FDG-PET dataset of 100 consecutive patients who were treated with SBRT for early stage NSCLC. Each patient's tumor was characterized by 722 radiomic features. An unsupervised two-way clustering method was used to identify groups of patients and radiomic features simultaneously. The groups of patients were compared in terms of survival and freedom from nodal failure. Meta-features were computed for building survival models to predict survival and free of nodal failure. RESULTS: Differences were found between 2 groups of patients when the patients were clustered into 3 groups in terms of both survival (p = 0.003) and freedom from nodal failure (p = 0.038). Average concordance measures for predicting survival and nodal failure were 0.640±0.029 and 0.664±0.063 respectively, better than those obtained by prediction models built upon clinical variables (p < 0.04). CONCLUSIONS: The evaluation results demonstrate that our method allows us to stratify patients and predict survival and freedom from nodal failure with better performance than current alternative methods.
引用
- Li H, Galperin-Aizenberg M, Pryma D, et al. Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Radiother Oncol. 2018. PMID: 30473058. doi:10.1016/j.radonc.2018.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。